Study on DBT vs mammography for breast cancer staging
Part of Cancer clinical trials.
This trial compares an advanced breast imaging technique (DBT) with standard mammography to better stage breast cancer in people with suspicious lesions (BI-RADS 4 or 5). It may help doctors plan more precise treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a breast lesion that is BI-RADS category 4 or 5 and has been confirmed as breast cancer by biopsy.
- You have not had any breast surgery in the past.
- You have not received chemotherapy or radiation therapy.
- You do not have a BI-RADS 1, 2, or 3 lesion.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of digital breast tomosynthesis (3D mammogram) systems to see which one makes breast masses and distortions easier to see. If you are a woman getting a routine screening mammogram, you may be able to join.
This research uses artificial intelligence to improve how doctors diagnose breast conditions from 3D mammogram images (called digital breast tomosynthesis). Researchers are testing whether AI can help detect breast cancer more accurately and predict treatment outcomes.
This study is testing a new high-resolution 3D mammogram machine. It is for women getting routine screening who do not have any breast symptoms or concerns.
This trial compares two imaging tests—CESM (a contrast-enhanced mammogram) and DBT (3D mammography)—to see which works best for women with dense breast tissue. It may help improve how early breast changes are found in dense breasts.
This study looks at how detailed breast imaging can help diagnose breast cancer when a mammogram is suspicious. If your mammogram result was “highly suspicious” and you have not had a biopsy yet, the trial may be able to use your images to improve future diagnosis.
This trial compares two advanced imaging methods—contrast-enhanced mammography and MRI—to see which is better for detecting breast cancer early in women at high risk. If you are at high risk and have not had breast cancer before, this study could help guide your future screening.
Hear when a new Digital Breast Tomosynthesis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.